Neuro Comfort
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80055968
- Status
- Active licence
- Licence date
- 26 November 2014
- Revision date
- 19 December 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 50 mg | Not calculated |
| Folate Source : Méthyltétrahydrofolate L-5 de calcium | 200 mcg | Not calculated |
| Riboflavine Source : Riboflavine | 200 mg | 400,000 µg |
| Magnésium Source : Glycinate de magnésium | 47.5 mg | 95,000 µg |
| Vitamine B12 Source : Méthylcobalamine | 500 mcg | 1,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Silice, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the frequency of migraine headaches when taken as a prophylactic. Helps in Tissue Formation. Helps to maintain and/or support cardiovascular health. An antioxidant for the maintenance of good health. Helps to maintain proper muscle function. Helps to prevent vitamin B12 deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80055968
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging